TGA Approval

FYNEFTA fingolimod (as hydrochloride) 0.25 mg capsule blister pack (315450)

ARTG ID

315450

ARTG Name

FYNEFTA fingolimod (as hydrochloride) 0.25 mg capsule blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

April 12, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

Ingredient Name

fingolimod hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

FYNEFTA fingolimod (as hydrochloride) 0.25 mg capsule blister pack (315450) - TGA 批准文号 | MedPath